Neuro-Oncology: The Podcast
Duración total:
16 h 45 min
Radio-Pathomic maps and MR perfusion
Neuro-Oncology: The Podcast
20:25
CSF proteomics in glioma
Neuro-Oncology: The Podcast
44:15
Vorasidenib in IDH mutant glioma
Neuro-Oncology: The Podcast
42:44
KL-50 in post TMZ MMR-deficient GBM
Neuro-Oncology: The Podcast
21:33
Measurable disease per FET-PET vs MRI in GBM
Neuro-Oncology: The Podcast
14:06
Pre-radiation chemotherapy in GBM
Neuro-Oncology: The Podcast
13:42
cIMPACT-NOW Update 8: grading of meningiomas
Neuro-Oncology: The Podcast
43:16
Residual tumor volume and survival after CCNU/TMZ in GBM
Neuro-Oncology: The Podcast
13:18
Alterations in RNA splicing between meningioma DNA methylation groups
Neuro-Oncology: The Podcast
33:46
The immune landscape of IDH mutant and IDHwt glioma
Neuro-Oncology: The Podcast
33:27
Equity-driven applications of AI in neuro-oncology
Neuro-Oncology: The Podcast
22:34
IDH mutant glioma across age groups
Neuro-Oncology: The Podcast
34:34
Contemporary molecular prognostic signatures in glioma
Neuro-Oncology: The Podcast
20:00
FDG PET in PCNSL
Neuro-Oncology: The Podcast
09:36
TMZ and MGMT in elderly GBM patients
Neuro-Oncology: The Podcast
17:46
IDH mutant glioma and IDH inhibitors
Neuro-Oncology: The Podcast
24:11
Leptomeningeal disease, a SNO and ASCO review
Neuro-Oncology: The Podcast
38:03
Cancer stems cell in GBM
Neuro-Oncology: The Podcast
31:27
Drug delivery across the blood-brain barrier
Neuro-Oncology: The Podcast
23:19
Gliomatosis cerebri in children
Neuro-Oncology: The Podcast
42:45
Immunotherapy drives mesenchymal shift in GBM
Neuro-Oncology: The Podcast
24:18
Long-term outcomes of pediatric patients with optic pathway glioma
Neuro-Oncology: The Podcast
15:11
NF1 mutation and neuronal hyperexcitability
Neuro-Oncology: The Podcast
22:56
Postoperative cerebellar mutism
Neuro-Oncology: The Podcast
32:20
Cell cycle checkpoints and alkylating agents
Neuro-Oncology: The Podcast
18:20
Liquid biopsy in CNS lymphoma
Neuro-Oncology: The Podcast
21:29
Immunotherapy for glioblastoma, lessons learned
Neuro-Oncology: The Podcast
29:55
TERTp mutation clonality in glioma
Neuro-Oncology: The Podcast
33:22
Liquid biopsy in H3K27M glioma
Neuro-Oncology: The Podcast
27:20
Glioma genetic profiles and electrophysiologic hyperexcitability
Neuro-Oncology: The Podcast
22:29
Epidemiology of glioma in Belgium
Neuro-Oncology: The Podcast
13:17
The Biology of H3K27M Mutant Gliomas
Neuro-Oncology: The Podcast
14:37
3D tumor volume assessment in PCNSL
Neuro-Oncology: The Podcast
27:36
Brain-tumor related epilepsy; a SNO consensus review
Neuro-Oncology: The Podcast
26:55
Vorasidenib and grading of IDH mutant astrocytoma
Neuro-Oncology: The Podcast
24:11
Insulin feedback and PI3K inhibition in GBM
Neuro-Oncology: The Podcast
25:07
SOX10 indel mutations in schwannomas
Neuro-Oncology: The Podcast
28:50
Dendritic cell vaccines in gliomas
Neuro-Oncology: The Podcast
17:22
Intrathecal trastuzumab for leptomeningeal metastases
Neuro-Oncology: The Podcast
21:05
Short term topiramate for radiation induced cytotoxic edema
Neuro-Oncology: The Podcast
14:10
